$CTIC Company News Insider filings one way to track

New Post Public Reply Private Reply Replies (0) Message Board

Jan 22, 2014 at 4:21 PM

$CTIC Company News

Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com

First Week Of CTIC January 2016 Options Trading 1:18 p.m. Today - TheStreet.com
Cell Therapeutics (CTIC) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. Today - TheStreet.com
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013 7:00 a.m. Jan. 21, 2014 - TheStreet.com
Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week 3:52 p.m. Jan. 17, 2014 - TheStreet.com
Cell Therapeutics provides corporate update, share rise 8:25 a.m. Jan. 14, 2014 - Seeking Alpha
Cell Therapeutics Regains Rights to Two In-Development Cancer Medicines 4:47 p.m. Jan. 13, 2014 - Wall St. Cheat Sheet
The J.P. Morgan Healthcare Confab Monday Morning News Dump 9:06 a.m. Jan. 13, 2014 - TheStreet.com
Cell Therapeutics regains rights to cancer compounds from Novartis 8:23 a.m. Jan. 13, 2014 - Seeking Alpha
Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from Novartis 5:01 a.m. Jan. 13, 2014 - benzinga.com
Time to Analyze Small-Caps Again 1:00 p.m. Jan. 10, 2014 - RealMoney.com
Cell Therapeutics Inc. (CTIC) Shares March Higher, Can It Continue? - Tale of the Tape 7:47 a.m. Jan. 7, 2014 - Zacks.com
BAX Recalls Parenteral Nutrition Injections - Analyst Blog 7:15 p.m. Jan. 6, 2014 - Zacks.com
Is Cell Therapeutics Turning Over A New Leaf In 2014? 11:35 a.m. Jan. 6, 2014 - Seeking Alpha
Cell Therapeutics rallies on NICE nod for Pixuvri 9:02 a.m. Jan. 6, 2014 - Seeking Alpha
FDA lifts partial clinical hold on Cell Therapeutics drug 7:04 a.m. Jan. 2, 2014 - Seeking Alpha
Cell Therapeutics Announces Removal of Partial Clinical Hold on Tosedostat 6:19 a.m. Jan. 2, 2014 - benzinga.com
2 Speculative, But Attractive $2 Biotech Plays 7:19 a.m. Dec. 30, 2013 - Seeking Alpha
BAX Up on FDA Nod and CE Marking - Analyst Blog 5:30 p.m. Dec. 24, 2013 - Zacks.com
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 4:56 a.m. Dec. 18, 2013 - benzinga.com
Cell Therapeutics outlines data from tosedostat study in AML or MDS 9:40 a.m. Dec. 10, 2013 - Seeking Alpha

Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 7:22 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 10:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 1:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds 1:30 a.m. Jan. 13, 2014 - PR Newswire - PRF
Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics 8:00 a.m. Jan. 7, 2014 - PR Newswire
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE 1:30 a.m. Jan. 6, 2014 - PR Newswire
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat 1:30 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 1:30 a.m. Dec. 18, 2013 - PR Newswire
Positive Trend Scan List: Cell Therapeutics Inc, Micron Technology, Tiger Oil and Energy, General Motors, Twitter Inc 9:25 a.m. Dec. 10, 2013 - PR Newswire
Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 1:30 a.m. Dec. 10, 2013 - PR Newswire
Integrated Safety and Efficacy Analysis of Phase 2 Clinical Trials of Pacritinib in Patients with Myelofibrosis and Low Platelet Counts Presented at ASH Annual Meeting 11:30 a.m. Dec. 9, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI® (pixantrone) in Germany 1:30 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:00 a.m. Dec. 2, 2013 - ACCESSWIRE
Bullish Stocks Analysis: Apple Inc, Facebook Inc, Cell Therapeutics Inc, Qihoo 360 Technology 9:32 a.m. Dec. 2, 2013 - ACCESSWIRE
Cell Therapeutics Receives $5 Million Milestone Payment for TRISENOX® 1:30 a.m. Dec. 2, 2013 - PR Newswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Notable News Buzz & Trend Analysis: Bank of America, The Boeing Company, Cell Therapeutics Inc, General Electric, Exxon Mobil Corporation 9:39 a.m. Nov. 18, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...